Ostatní
Návod 
Kura Oncology, Inc.
KURA
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.9B
Obrat
0B
Zisk
0B
Aktiva
1B
Dluh
0B
ROE
-89%
ROA
-33%
PE
-3
PS
11
Cena 1R
5-12
⌀ Cena
8.02
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
29-04-2026
Poslední dividenda
Profil
Kura Oncology, Inc., biofarmaceutická společnost v klinickém stadiu, vyvíjí léky pro léčbu rakoviny ve Spojených státech. Potrubí společnosti se skládá z malých molekulárních produktů, které se zaměřují na rakovinu. Jeho hlavními kandidáty jsou ziftomenib, malý inhibitor molekul metyltransferázy 2A specifické pro menin-lysinu K, proteinový interakce pro léčbu geneticky definovaných podskupin akutních leukemií, včetně akutní myeloidní leukemie a akutní lymfoblastické leukemie; a tipifarnib, perorálně biologicky dostupný inhibitor farnesyltransferázy, který je v klinických studiích fáze II pro léčbu solidních tumorů a hematologických indikací. Společnost klinicky spolupracuje s přípravkem Novartis na hodnocení kombinace tipifarnibu a alpelisibu u pacientů s dlaždicobuněčným karcinomem hlavy a krku, jejichž nádory mají zvýšenou expresi HRAS nebo mutaci a/nebo amplifikaci PIK3CA. Společnost Kura Oncology, Inc. byla založena v roce 2014 a sídlí v kalifornském San Diegu.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
192
Založení
2015-09-16
Podobné společnosti
$ 3.67
- $ 0.15
$ 11.33
+ $ 0.12
$ 2.77
- $ 0.12
$ 3.05
+ $ 0.18
$ 14.36
+ $ 0.04
$ 7.87
- $ 0.01
$ 8.66
+ $ 0.35
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 67.5 | 67.5 | 53.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cost of Revenues | 3.7 | 0.1 | 0.0 | 0.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Gross Profit | 63.8 | 67.4 | 53.9 | -0.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 17.3 | 20.8 | 15.3 | 14.1 | 53.9 | 0.0 | 0.0 | 0.0 | 1.3 | 0.0 | |
| Cost of Revenues | 0.5 | 3.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.2 | 0.2 | 0.2 | |
| Gross Profit | 16.9 | 17.5 | 15.3 | 14.1 | 53.9 | 0.0 | -0.2 | -0.2 | 1.1 | -0.2 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 115.2 | 92.8 | 84.7 | 60.4 | 47.8 | 46.8 | 26.4 | 20.4 | 17.8 | 0.7 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 50.6 | 47.1 | 46.5 | 31.5 | 19.7 | 16.1 | 9.7 | 8.0 | 6.1 | 1.3 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Depreciation & Amortization | -6.3 | 1.0 | 0.8 | 0.8 | 0.8 | 0.6 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Operating Expenses | 367.9 | 371.1 | 247.1 | 165.8 | 139.9 | 131.3 | 91.9 | 67.5 | 62.9 | 36.1 | 28.4 | 23.9 | 3.9 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Operating Income | -303.6 | -303.6 | -193.2 | -165.8 | -140.6 | -131.8 | -92.1 | -67.5 | -62.9 | -36.1 | -28.4 | -23.9 | -3.9 | 0.0 | 0.0 | 0.0 | 0.0 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 32.5 | 29.3 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 14.0 | 13.1 | ||
| Depreciation & Amortization | 0.4 | 0.2 | 0.2 | -7.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | ||
| Total Operating Expenses | 103.6 | 97.5 | 88.0 | 78.8 | 76.3 | 59.9 | 56.2 | 54.2 | 46.5 | 42.5 | ||
| Operating Income | -86.3 | -80.0 | -72.7 | -64.7 | -22.5 | -59.9 | -56.4 | -54.5 | -46.8 | -38.6 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 26.4 | 26.8 | 22.8 | 14.7 | 4.3 | 1.2 | 2.8 | 4.7 | 3.2 | 0.8 | 0.5 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Interest Expense | 1.1 | 1.5 | 1.6 | 1.5 | 0.2 | 0.4 | 0.6 | 0.6 | 1.0 | 0.9 | 0.6 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Expense | 25.3 | 25.3 | 21.2 | 13.2 | 4.8 | 1.4 | 2.5 | 4.3 | 2.4 | 0.6 | 0.8 | 1.2 | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | |
| IBT | -278.4 | -278.4 | -172.0 | -152.6 | -135.8 | -130.5 | -89.6 | -63.1 | -60.4 | -35.4 | -27.6 | -22.6 | -3.7 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Income Tax Expense | 0.3 | 0.3 | 2.0 | 0.0 | 0.2 | -0.6 | -0.2 | 0.0 | 3.4 | 0.0 | 0.0 | 0.0 | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Net Income | -278.7 | -278.7 | -174.0 | -152.6 | -136.1 | -129.9 | -89.4 | -63.1 | -60.4 | -35.4 | -27.6 | -22.6 | -3.7 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 5.7 | 5.9 | 6.9 | 7.9 | 5.7 | 5.9 | 6.0 | 5.3 | 4.4 | 4.3 | ||
| Interest Expense | 0.3 | 0.0 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | ||
| Other Expense | 5.3 | 5.9 | 6.5 | 7.5 | 5.3 | 5.5 | 5.6 | 4.9 | 4.0 | 3.9 | ||
| IBT | -80.9 | -74.1 | -66.1 | -57.2 | -17.2 | -54.4 | -50.8 | -49.5 | -42.8 | -38.6 | ||
| Income Tax Expense | 0.1 | 0.0 | 0.0 | 0.2 | 2.0 | 0.0 | 0.0 | 0.0 | 2.9 | 0.4 | ||
| Net Income | -81.0 | -74.1 | -66.1 | -57.4 | -19.2 | -54.4 | -50.8 | -49.5 | -42.8 | -38.6 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-2.08 | $-2.03 | $-1.96 | $-1.68 | $-1.51 | $-1.72 | $-1.52 | $-1.47 | $-2.28 | $-0.25 | $-0.01 | $-0.01 | $0.00 | $0.00 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-2.08 | $-2.03 | $-1.96 | $-1.68 | $-1.51 | $-1.72 | $-1.52 | $-1.47 | $-2.28 | $-0.25 | $-0.01 | $-0.01 | $0.00 | $0.00 | |
| Shares Outstanding | 88.1 | 87.7 | 86.2 | 73.2 | 67.0 | 66.4 | 53.1 | 41.9 | 35.2 | 23.2 | 18.7 | 9.9 | 14.5 | 5.0 | 5.0 | 5.0 | 5.0 | |
| Diluted Shares Outstanding | 88.1 | 87.7 | 86.2 | 73.2 | 67.0 | 66.4 | 53.1 | 41.9 | 35.2 | 23.2 | 18.7 | 9.9 | 14.5 | 5.0 | 5.0 | 5.0 | 5.0 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.55 | $-0.50 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.55 | $-0.50 | ||
| Shares Outstanding | 88.1 | 87.6 | 87.6 | 87.4 | 87.1 | 87.0 | 86.6 | 83.9 | 77.3 | 77.2 | ||
| Diluted Shares Outstanding | 88.1 | 87.6 | 87.6 | 87.4 | 87.1 | 87.0 | 86.6 | 83.9 | 77.3 | 77.2 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 45.2 | 224.5 | 37.3 | 51.8 | 90.7 | 325.5 | 26.1 | 16.1 | 11.4 | 9.7 | 15.4 | 1.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Short Term Investments | 446.3 | 502.9 | 386.6 | 386.2 | 427.3 | 307.8 | 210.8 | 162.9 | 81.7 | 58.1 | 70.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 491.5 | 727.4 | 424.0 | 438.0 | 518.0 | 633.3 | 236.9 | 179.0 | 93.1 | 67.8 | 85.7 | 1.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Accounts Receivable | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.2 | 0.3 | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Assets | 8.2 | 17.4 | 8.5 | 8.4 | 4.3 | 4.0 | 2.7 | 2.0 | 1.3 | 0.7 | 0.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Current Assets | 499.8 | 744.8 | 432.5 | 446.4 | 522.3 | 637.3 | 239.6 | 181.2 | 94.6 | 68.8 | 86.9 | 1.2 | 0.0 | 0.0 | 0.0 | 0.0 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 95.3 | 81.9 | 51.3 | 224.5 | 49.5 | 45.2 | 41.5 | 37.3 | 28.7 | 49.1 | |
| Short Term Investments | 454.4 | 548.8 | 606.9 | 502.9 | 405.8 | 446.3 | 485.6 | 386.6 | 423.9 | 427.9 | |
| Total Cash & ST Investments | 549.7 | 630.7 | 658.2 | 727.4 | 455.3 | 491.5 | 527.1 | 424.0 | 452.6 | 477.0 | |
| Accounts Receivable | 39.2 | 4.6 | 48.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Assets | 31.8 | 24.8 | 17.3 | 17.4 | 7.9 | 8.2 | 10.7 | 13.1 | 7.3 | 8.7 | |
| Total Current Assets | 620.7 | 660.1 | 724.2 | 744.8 | 463.2 | 499.8 | 537.8 | 432.5 | 459.9 | 477.0 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 7.9 | 7.5 | 8.9 | 6.4 | 8.2 | 8.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 7.2 | 7.8 | 7.6 | 3.5 | 3.5 | 1.6 | 2.3 | 1.2 | 1.2 | 1.0 | 0.3 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Long-Term Assets | 15.3 | 15.3 | 16.5 | 9.9 | 11.8 | 9.9 | 2.4 | 1.2 | 1.2 | 1.0 | 0.4 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Assets | 515.1 | 760.2 | 448.9 | 456.3 | 534.1 | 647.2 | 242.0 | 182.4 | 95.9 | 69.8 | 87.3 | 1.4 | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 14.9 | 11.8 | 10.5 | 7.5 | 7.4 | 7.9 | 8.4 | 8.9 | 9.3 | 5.2 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.2 | 0.2 | |
| Other Long-Term Assets | 13.8 | 10.6 | 9.1 | 7.8 | 8.2 | 7.4 | 7.7 | 7.4 | 4.3 | 3.7 | |
| Total Long-Term Assets | 28.7 | 22.4 | 19.6 | 15.3 | 15.6 | 15.3 | 16.1 | 16.5 | 13.9 | 9.1 | |
| Total Assets | 649.4 | 682.4 | 743.8 | 760.2 | 478.8 | 515.1 | 553.9 | 448.9 | 473.8 | 494.7 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 2.1 | 1.5 | 2.3 | 1.5 | 3.2 | 2.8 | 3.5 | 4.1 | 1.5 | 1.4 | 1.8 | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Short-Term Debt | 2.3 | 4.5 | 3.0 | 2.3 | 2.3 | 5.1 | 0.3 | 0.0 | 1.5 | 0.0 | 0.0 | 2.0 | 0.1 | 0.1 | 0.1 | 0.1 | |
| Other Current Liabilities | 29.1 | 46.4 | 30.0 | 20.2 | 17.0 | 18.2 | 11.8 | 9.5 | 7.0 | 4.0 | 3.2 | 0.6 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Current Liabilities | 33.5 | 78.7 | 35.3 | 24.1 | 22.5 | 26.0 | 15.6 | 13.6 | 10.0 | 5.5 | 5.1 | 3.0 | 0.1 | 0.1 | 0.1 | 0.1 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 4.7 | 1.7 | 4.6 | 1.5 | 3.0 | 2.1 | 7.5 | 2.3 | 1.8 | 2.3 | |
| Short-Term Debt | 5.8 | 4.8 | 3.8 | 4.5 | 3.4 | 2.3 | 1.4 | 3.0 | 3.4 | 4.7 | |
| Other Current Liabilities | 62.1 | 51.2 | 38.2 | 46.4 | 34.0 | 29.1 | 23.4 | 30.0 | 22.4 | 16.9 | |
| Current Liabilities | 121.3 | 107.2 | 89.8 | 78.7 | 40.4 | 33.5 | 32.3 | 35.3 | 27.5 | 23.9 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 8.6 | 12.1 | 15.7 | 11.7 | 4.6 | 9.9 | 7.3 | 7.5 | 5.6 | 7.3 | 0.0 | 0.5 | 0.1 | 0.1 | 0.1 | 0.0 | |
| Capital Leases | 5.8 | 7.1 | 7.9 | 4.9 | 6.9 | 7.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 49.0 | 346.5 | 51.7 | 36.0 | 27.4 | 36.3 | 23.2 | 21.4 | 16.0 | 12.9 | 5.2 | 4.8 | 0.1 | 0.1 | 0.1 | 0.1 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 13.7 | 14.7 | 15.5 | 12.1 | 13.2 | 14.4 | 15.6 | 15.7 | 15.7 | 10.7 | |
| Capital Leases | 9.8 | 9.9 | 9.8 | 7.1 | 7.2 | 7.3 | 7.6 | 6.4 | 8.1 | 3.8 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 406.8 | 376.9 | 379.4 | 346.5 | 55.1 | 49.0 | 48.8 | 51.7 | 43.8 | 11.2 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -821.8 | -895.4 | -721.4 | -568.8 | -433.0 | -302.5 | -212.9 | -149.7 | -89.3 | -53.9 | -26.3 | -3.7 | -0.2 | -0.1 | -0.1 | -0.1 | |
| Comprehensive Income | -0.5 | 0.8 | -1.3 | -8.0 | -1.8 | 0.0 | 0.3 | -0.1 | 0.0 | 0.0 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Common Equity | 466.1 | 413.6 | 397.3 | -568.8 | -433.0 | -302.5 | -212.9 | -149.7 | 79.9 | 56.9 | 82.1 | -3.4 | -0.1 | -0.1 | -0.1 | 0.0 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -1,093.1 | -1,019.0 | -952.9 | -895.4 | -876.2 | -821.8 | -771.0 | -721.4 | -678.7 | -640.1 | |
| Comprehensive Income | 0.9 | 0.7 | 1.0 | 0.8 | 1.1 | -0.5 | -0.8 | -1.3 | -3.5 | -5.2 | |
| Total Common Equity | 242.5 | 305.5 | 364.4 | 413.6 | 423.8 | 466.1 | 505.1 | 397.3 | 429.9 | -640.1 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 16.7 | 16.6 | 17.2 | 14.0 | 6.9 | 15.0 | 7.5 | 7.5 | 7.1 | 7.3 | 0.0 | 2.5 | 0.2 | 0.2 | 0.1 | 0.1 | |
| Book Value | 466.1 | 413.6 | 397.3 | 420.3 | 506.6 | 610.9 | 218.8 | 161.0 | 79.9 | 56.9 | 82.1 | -3.4 | -0.1 | -0.1 | -0.1 | 0.0 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 242.5 | 305.5 | 364.4 | 413.6 | 423.8 | 466.1 | 505.1 | 397.3 | 429.9 | -640.1 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -181.8 | -278.7 | -174.0 | -152.6 | -135.8 | -130.5 | -89.6 | -63.1 | -60.4 | -35.4 | -27.6 | -22.6 | -3.7 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Depreciation & Amortization | 0.9 | -7.5 | 0.8 | 0.8 | 0.8 | 0.6 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Stock-Based Compensation | 31.2 | 37.1 | 33.9 | 28.1 | 26.3 | 23.6 | 12.8 | 9.4 | 8.7 | 4.5 | 2.1 | 2.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Change Working Capital | 6.9 | 184.4 | 286.2 | 7.8 | -3.0 | -3.2 | 6.4 | 0.1 | 4.4 | 2.6 | -0.1 | 1.4 | -1.7 | 0.0 | 0.0 | -0.1 | 0.0 | |
| Change In Accounts Receivable | 0.0 | -6.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.1 | 0.1 | -0.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Change In Accounts Payable | 8.4 | 4.5 | 15.2 | 0.0 | -0.8 | -2.5 | 5.7 | 0.0 | 5.1 | 3.6 | 0.5 | 2.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Change In Inventories | 0.0 | -0.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.4 | -0.8 | -0.2 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Non-cash Items | 6.9 | 0.5 | -12.6 | -8.9 | 1.7 | 0.4 | 0.4 | -1.1 | 0.2 | 0.1 | 0.0 | 0.6 | 4.5 | 0.0 | 0.0 | 0.1 | 0.0 | |
| Cash from Operations | -154.7 | 0.0 | 0.0 | -124.8 | -110.1 | -104.6 | -69.8 | -54.8 | -48.7 | -28.4 | -25.3 | -17.9 | -0.8 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -81.0 | -74.1 | -66.1 | -57.4 | -19.2 | -54.4 | -50.8 | -49.5 | -42.8 | -38.6 | |
| Depreciation & Amortization | 1.7 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | |
| Stock-Based Compensation | 11.4 | 11.0 | 6.9 | 7.8 | 8.6 | 8.3 | 8.4 | 8.5 | 7.2 | 7.1 | |
| Change Working Capital | 187.8 | -44.2 | 35.9 | -20.1 | 282.3 | 0.1 | 3.1 | -4.9 | 3.7 | 5.0 | |
| Change In Accounts Receivable | 27.1 | -31.4 | 44.2 | -46.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Change In Accounts Payable | -10.3 | 0.0 | 0.0 | -5.4 | 12.7 | 0.0 | -0.1 | -3.1 | 7.6 | 3.9 | |
| Change In Inventories | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Non-cash Items | -2.6 | 26.6 | -5.7 | -2.5 | -2.7 | 2.4 | -3.4 | -3.1 | -7.6 | 0.1 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -34.3 | -29.0 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.1 | -6.6 | -0.5 | -0.2 | -0.6 | -1.1 | -2.2 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | -553.1 | -761.6 | -659.0 | -409.8 | -270.7 | -445.7 | -321.0 | -227.6 | -237.4 | -100.6 | -56.4 | -76.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 551.8 | 755.1 | 557.9 | 425.5 | 303.9 | 320.0 | 223.2 | 181.2 | 158.1 | 77.2 | 68.6 | 6.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | -95.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Investing | -1.4 | 0.0 | 0.0 | 15.6 | 32.6 | -126.8 | -99.9 | -46.3 | -79.3 | -23.4 | 12.2 | -70.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -2.3 | -2.6 | -1.5 | -0.3 | -0.4 | 0.0 | 0.0 | -0.1 | 0.0 | 0.0 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | -239.8 | 0.0 | 0.0 | -268.7 | -240.6 | 0.0 | -161.7 | -195.1 | -99.7 | -96.7 | |
| Sales of Investment | 177.5 | 0.0 | 0.0 | 167.6 | 146.0 | 0.0 | 204.9 | 99.8 | 141.9 | 105.3 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 42.2 | 8.6 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -7.3 | -0.3 | 0.0 | -1.3 | -0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 3.7 | 16.6 | -0.6 | 3.2 | 7.1 | -0.9 | 7.7 | 7.5 | 1.7 | 0.1 | 7.3 | -2.5 | 2.3 | 0.1 | 0.1 | 0.1 | 0.1 | |
| Issuance of Common Stock | 152.2 | 0.0 | 0.0 | 93.6 | 24.7 | 0.0 | 459.3 | 108.2 | 132.2 | 53.7 | 0.0 | 97.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 97.3 | 0.0 | 0.0 | 1.2 | 13.8 | 3.8 | 10.2 | 2.9 | 1.7 | 0.2 | 7.5 | 5.0 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Financing | 152.2 | 0.0 | 0.0 | 94.8 | 38.6 | -3.4 | 469.3 | 111.1 | 132.6 | 53.6 | 7.5 | 102.9 | 2.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 19.5 | 0.0 | 0.1 | 2.8 | 0.0 | -0.1 | -0.2 | -0.2 | -0.2 | 4.4 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.7 | 0.1 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.7 | 0.1 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.7 | 0.1 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -4.2 | -75.4 | 187.1 | -14.5 | -38.9 | -234.8 | 299.6 | 10.0 | 4.7 | 1.7 | -5.7 | 14.3 | 1.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Closing Cash Balance | 45.2 | 149.1 | 224.5 | 37.3 | 52.0 | 90.9 | 325.7 | 26.1 | 16.1 | 11.4 | 9.7 | 15.4 | 1.1 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 53.8 | 13.3 | 30.7 | -173.2 | 175.0 | 4.3 | 3.7 | 4.2 | 8.6 | -20.6 | |
| Closing Cash Balance | 149.1 | 95.3 | 81.9 | 51.3 | 224.5 | 49.5 | 45.2 | 41.5 | 37.3 | 28.7 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -154.8 | -70.7 | 133.8 | -125.0 | -110.7 | -105.7 | -72.0 | -54.8 | -48.7 | -28.4 | -25.3 | -18.0 | -0.8 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Real Free Cash Flow | -186.0 | -107.8 | 99.9 | -153.1 | -137.0 | -129.3 | -84.8 | -64.2 | -57.3 | -33.0 | -27.4 | -20.2 | -0.8 | 0.0 | 0.0 | 0.0 | 0.0 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 115.0 | -83.2 | -30.2 | -72.2 | 268.8 | -43.4 | -42.5 | -48.9 | -34.3 | -29.0 | |
| Real Free Cash Flow | 103.6 | -94.2 | -37.2 | -80.1 | 260.1 | -51.8 | -51.0 | -57.4 | -41.5 | -36.1 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -2.6 | -8.7 | -1.4 |
| P/S | 10.8 | 133.8 | 9.4 |
| P/B | 3 | 2.9 | 5.2 |
| P/FCF | -6.7 | -7.5 | -1.5 |
| Market cap | $0.9 | $1.0 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 3 % | 546.8 % | 0 % |
| Debt to Income | -7 % | -208.6 % | 0 % |
| Debt to Free cash flow | -18.1 % | -509.7 % | 0 % |
| Interest expense percentage | -0.4 % | -5.4 % | 44.7 % |
| Current ratio | 5.1 | 11.2 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -114.9 % | -12.8 % | 0 % |
| ROA | -42.9 % | -100.9 % | 0 % |
| CapEx to Revenue | 4.5 % | 1 % | 0 % |
| RaD to Revenue | 0 % | 816.5 % | 0 % |
| ROEM | 351,468.8 | 3180.5 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 96.9 % | 13.8 % | 68.7 % |
| Operating margin | -230.5 % | -1159.6 % | 35.5 % |
| Net margin | -208.5 % | -1073.9 % | 9.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | 0 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 87.6 mil | 35.6 mil |
| Employee count | 0.2 tis | 0.1 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
